W.077TSMC’s board approved $40.9B of capital appropriations, bringing this year’s to $146.6B, 2.2 times 2025’s. It also cleared up to $500M each for Anthropic and OpenAI shares
TSMC’s board approved about $40.93B of capital appropriations on November 10, 2.7× the amount it approved in November 2025. The four meetings of 2026 approved $146.6B, against $68.0B in 2025. The board also cleared up to $500M of Anthropic shares at the IPO price and up to $500M of OpenAI preferred stock.
What the board approved
The appropriation is the second largest in the series we compiled. TSMC said the $40.93B was to meet long-term capacity plans based on market demand forecasts and its technology roadmap. It listed four uses without a split: advanced technology capacity; advanced packaging, mature or specialty capacity; fab construction and facility systems; and 2027 research capital, sustaining capex and capitalized leased assets. Only February’s $44.96B was larger. Unlike February’s and May’s, this meeting approved no capital injection into a subsidiary.
Approvals have run ahead of spending. Appropriations are approvals, not spending. The $68.0B approved in 2025 was 1.7× the $40.9B TSMC spent that year; the $146.6B approved in 2026 is 2.3× to 2.4× its $60–64B capex budget, which it reiterated on October 15. TSMC spent $40.64B in the first nine months, so the budget leaves $19.36B–$23.36B for the fourth quarter, more than any quarter so far this year.
November’s $40.9B is 2.7× the November before; only February 2026’s was larger
Capital appropriations approved at each TSMC board meeting, $B, February 2024 to November 2026; 2026 in strong grey. Amounts as stated in TSMC’s board-meeting releases. The 2024 mid-year meeting was held on June 5.
The figures behind the chart
| Meeting | Appropriations, $M |
|---|---|
| Feb 24 | 9,421.48 |
| Jun 24 | 17,356.20 |
| Aug 24 | 29,615.47 |
| Nov 24 | 15,479.95 |
| Feb 25 | 17,141.40 |
| May 25 | 15,247.70 |
| Aug 25 | 20,657.50 |
| Nov 25 | 14,981.60 |
| Feb 26 | 44,962.00 |
| May 26 | 31,284.30 |
| Aug 26 | 29,442.50 |
| Nov 26 | 40,926.70 |
Appropriations approved in 2026 are more than twice this year’s capex budget
$B by calendar year. Faint grey and strong grey: the sum of the four board meetings’ appropriations. Grey: capital expenditure for 2025 and 2026; for 2026, the first nine months, with the outline running to the top of the $60–64B budget.
The stakes in Anthropic and OpenAI
TSMC’s Anthropic purchase is the smallest of seven in the IPO’s private placement. Anthropic’s amended prospectus, also filed November 10, lists TSMC Partners, Ltd. buying 6,756,756 nonvoting Class N shares, about $500M at the $74 midpoint, in a $26.0B placement at the IPO price; TSMC’s own resolution refers to Anthropic’s common shares and names no buyer. At the $70–78 range, $500M buys 6.41M to 7.14M shares. Google and Nvidia are buying about $10B each.
The OpenAI terms are not public. The resolution gives no price, valuation or timing for the OpenAI preferred stock. OpenAI raised about $11B at a $1.25T valuation before the new money, Bloomberg reported on November 6, in a round that could reach about $20B; no source we found says whether TSMC’s purchase is part of it. TSMC gave no reason for either investment. The board also approved up to $500M for an investment company to make strategic investments in the semiconductor industry and related ecosystem, and raised its quarterly dividend to NT$9 a share from NT$7.
TSMC’s $500M is about 1.9% of Anthropic’s $26B placement
Buyers in the concurrent private placement listed in Anthropic’s S-1/A of November 10, $B at the IPO price; TSMC Partners’ amount is at the $74 midpoint.
What this changes on inthesingularity.ai
- Unit growth: TSMC’s appropriations, $146.6B approved in 2026 against $68.0B in 2025, are a leading series for foundry capacity worth adding next to capex.
- Who funds the labs?: TSMC would join the suppliers taking equity in both leading labs if both purchases go ahead; the OpenAI purchase’s price and timing are worth tracking when disclosed.
- Worth tracking: whether TSMC’s 2027 capex guidance, expected with fourth-quarter results in January, follows the approvals up.
Sources and method
| Item | Figure | Source |
|---|---|---|
| Board, Nov 10 | Capital appropriations of about $40,926.70M; up to $500M in Anthropic common shares at the IPO price; up to $500M of OpenAI Group PBC preferred stock; up to $500M for an investment company; NT$9 dividend for Q3 | TSMC, “Board of Directors Meeting Resolutions”, Nov 10 |
| Board, Nov 10 | The same resolutions, as filed | TSMC Form 6-K, Nov 10 |
| Earlier approvals | Feb, Jun, Aug, Nov 2024; Feb, May, Aug, Nov 2025; Feb, May, Aug 2026 | TSMC board resolutions: 2024 Feb, Jun, Aug, Nov · 2025 Feb, May, Aug, Nov · 2026 Feb, May, Aug |
| Capex 2026 | Budget $60–64B reiterated; cash and marketable securities about $126B | TSMC Q3 2026 call transcript, Oct 15 |
| Capex by quarter | 2026: $11.1B, $15.7B, $13.84B | TSMC 3Q26 management report |
| Capex 2025 | $40.9B | TSMC Q4 2025 call transcript, Jan 2026 |
| Placement | Buyers and amounts in the $26.0B Class N placement; TSMC Partners, Ltd. 6,756,756 shares; range $70–78 | Anthropic S-1/A No. 2, Nov 10 |
| OpenAI round | About $11B raised at a $1.25T pre-money valuation; the round could reach about $20B | TechCrunch, citing Bloomberg, Nov 6 |
Earlier board releases: Feb 2024, Jun 2024, Aug 2024, Nov 2024, Feb 2025, May 2025, Aug 2025, Nov 2025, Feb 2026, May 2026, Aug 2026.
Years: each is the sum of its four meetings: 2024 $71.87B, 2025 $68.03B, 2026 $146.62B; 146.62 ÷ 68.03 = 2.16. November: 40,926.7 ÷ 14,981.6 = 2.73. Against capex: 68.03 ÷ 40.9 = 1.66; 146.62 ÷ 64 = 2.29 and ÷ 60 = 2.44. Nine months: 11.1 + 15.7 + 13.84 = 40.64; fourth quarter at budget: 60 − 40.64 = 19.36, 64 − 40.64 = 23.36. Stakes: $1.0B ÷ $126B = 0.79%; with the investment company, $1.5B ÷ $126B = 1.19%. Shares: 500M ÷ 78 = 6,410,256; ÷ 74 = 6,756,756; ÷ 70 = 7,142,857. Placement: listed amounts sum to $26.0B; 0.5 ÷ 26.0 = 1.9%.
Wire reports are written within hours of the news, on a six-hour schedule. Each lists its sources and shows the arithmetic behind its figures. Not investment advice.